The online reference source for the interventional NeuroRadiology, Neurology and NeuroSurgery community

Intraarterial Bevacizumab Administration Through the Middle Meningeal Artery for Chronic Subdural Hematoma

Presentation of the best cases submitted by LINNC online members

Last update on June 5, 2024

Expert Panel:

Thaweesak AURBOONYAWAT, Edoardo BOCCARDI, Ricardo HANEL, Monika KILLER-OBERPFALZER, Saleh LAMIN, Raul G. NOGUEIRA, Sirintara PONGPECH, Naci KOCER

Course Director:

Jacques MORET, Laurent SPELLE, Vitor MENDES PEREIRA

Speaker:

Jane KHALIFE

At LINNC Paris 2024, Dr. Jane Khalife presents an innovative approach to treating chronic subdural hematoma (cSDH) through intra-arterial bevacizumab administration via the middle meningeal artery (MMA). With recurrence rates high and traditional treatments carrying risks, this pharmacological therapy offers a potentially safer alternative to MMA embolization. Learn how this approach aims to reduce risks, streamline procedures, and preserve the MMA, while showing promise for a more effective, cost-efficient treatment option. Watch the full presentation now!